30

Beijing Leadman Biochemistry Co LtdSHE 300289 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

0.415

Micro

Exchange

XSHE - Shenzhen Stock Exchange

300289.SZ Stock Analysis

30

Uncovered

Beijing Leadman Biochemistry Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

31/100

Low score

Market cap $B

0.415

Dividend yield

0.21 %

Shares outstanding

544.01 B

Beijing Leadman Biochemistry Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic products. The company is headquartered in Beijing, Beijing and currently employs 522 full-time employees. The company went IPO on 2012-02-16. Its diagnostic reagents include chemiluminescence diagnostic reagents and biochemical diagnostic agents, such as hepatitis B virus attributes and tumor markers. The firm also produces diagnostic instruments and biochemical raw materials. Its diagnostic instruments include automatic luminescence immunity analyzers, among others. Its products are applied in various fields, including liver diseases, kidney diseases, cardiovascular diseases, immunological diseases and diabetes, among others. The firm mainly operates businesses in domestic market.

View Section: Eyestock Rating